Pfizer: Dermatitis, Atopic trials

The registry lists 58 Dermatitis, Atopic studies with Pfizer as lead sponsor. 12 are open to participants now and 34 have results posted.

Phase 1 14Phase 2 15Phase 3 18Phase 4 2No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other TherapiesNot yet recruitingNCT07887867
• Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of AgeNot yet recruitingNCT07823595Phase 3
• A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe EczemaRecruitingNCT07783425Phase 3
• A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe EczemaRecruitingNCT07765888Phase 3
• A Study to Learn About Study Medicine Called PF-08049820 in People With EczemaRecruitingNCT07216027Phase 2
• Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.RecruitingNCT06899204
• A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe EczemaRecruitingNCT06807281Phase 3
• FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsRecruitingNCT06564389Phase 1
• A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their OffspringRecruitingNCT05721937
• A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.RecruitingNCT05689151
• Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)AvailableNCT05466578
• A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic DermatitisRecruitingNCT05391061
• A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by InjectionTerminatedNCT05732454Phase 2/3Results posted
• A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.CompletedNCT05375955Phase 2Results posted
• A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in IndiaCompletedNCT05375929Phase 3Results posted
• A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic DermatitisTerminatedNCT05250115Results posted
• A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations.CompletedNCT04903093Phase 1Results posted
• Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic DermatitisCompletedNCT04668066Phase 1Results posted
• Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque PsoriasisCompletedNCT04664153Phase 2Results posted
• A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic DermatitisTerminatedNCT04498403Phase 3Results posted
• Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic DermatitisCompletedNCT04360187Phase 3Results posted
• Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical TherapyCompletedNCT04345367Phase 3Results posted
• A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT04162769Phase 2Results posted
• A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic DermatitisCompletedNCT04040192Phase 3Results posted
• Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic DermatitisCompletedNCT03954158Phase 2Results posted
• Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic DermatitisCompletedNCT03915496Phase 2Results posted
• Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic DermatitisCompletedNCT03903822Phase 2Results posted
• JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic DermatitisCompletedNCT03796676Phase 3Results posted
• Study of PF 04965842 Effect on MATE1/2K Activity in Healthy ParticipantsCompletedNCT03796182Phase 1Results posted
• Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical TherapyCompletedNCT03720470Phase 3Results posted
• Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring SubjectsCompletedNCT03627767Phase 3Results posted
• Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic DermatitisCompletedNCT03575871Phase 3Results posted
• A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate ADTerminatedNCT03539601Phase 4Results posted
• A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic DermatitisCompletedNCT03356977Phase 4Results posted
• Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic DermatitisCompletedNCT03349060Phase 3Results posted
• A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic DermatitisCompletedNCT03260595Phase 1Results posted
• Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic DermatitisCompletedNCT03233529Phase 2Results posted
• Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic DermatitisCompletedNCT02780167Phase 2Results posted
• Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic DermatitisCompletedNCT02743871Phase 1Results posted
• Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic DermatitisCompletedNCT02118792Phase 3Results posted
• Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic DermatitisCompletedNCT02118766Phase 3Results posted
• Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)CompletedNCT02001181Phase 2Results posted
• Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic DermatitisCompletedNCT01652885Phase 1/2Results posted
• Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic DermatitisCompletedNCT01602341Phase 2Results posted
• Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic DermatitisCompletedNCT01301508Phase 2Results posted
• A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian PatientsCompletedNCT00929981Results posted
• A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults.CompletedNCT07284173Phase 1
• A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female ParticipantsCompletedNCT07190430Phase 1
• A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy AdultsCompletedNCT07172321Phase 1
• A Study to Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the Body in Healthy AdultsCompletedNCT06686797Phase 1
• Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)CompletedNCT06353087
• A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic DermatitisActive, not recruitingNCT05995964Phase 2
• A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.Active, not recruitingNCT05387980
• Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic DermatitisNo longer availableNCT04564755
• A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy ParticipantsCompletedNCT04135560Phase 1
• Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial FormulationCompletedNCT04065633Phase 1
• Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842.CompletedNCT03634345Phase 1
• Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic DermatitisCompletedNCT03422822Phase 3